Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
INTRODUCTION

 Thalassemia is an inherited autosomal recessive
  blood disorder.
 which results in excessive destruction...
ALPHA
THALASSEMIA




              THALASSEMA


    BETA
THALASSEMIA
Alpha Thalassemia

 Alpha thalassemia is the result of changes in the
  genes for the alpha globin component in hemoglobi...
ETIOLOGY

 Mutation in the DNA of cells that produce
  hemoglobin
 It is a form of thalassemia involving the
  genes HB1...
PATHPHYSIOLOGY

 Alpha thalassemia results when there is
  disturbance in production of α-globin from any
  or all four o...
 Therefore, alpha thalassemia occurs when there
  is a disturbance in production of α-globin from
  any or all four of th...
 Normal production of alpha chains is absent which
  results in excess production of gamma- globin chains in
  the fetus ...
CLINICAL PRESENTATION
 Shortage of red blood cells- Anemia
 Pale skin
 Weakness
 Fatigue
 Enlarged liver and spleen- ...
 Heart defects
 Abnormalities of the urinary system or genitalia
 Hb Bart syndrome can cause complications in pregnancy...
Treatment of Alpha Thalassemia
 Treatment for thalassemia often involves regular
  blood transfusions and folate suppleme...
Surgical Treatment
 Perform splenectomy if transfusion
  requirements are increasing.
 Surgical or orthodontic correctio...
Medications
FOLIC ACID- ORAL
FOLIC ACID - INJECTION
FOLIC ACID - ORAL

 BRAND NAME(S): FA-8

 USES
  Folic acid is the man-made form of folate which is a
   B6-vitamin nat...
SIDE EFFECTS

Folic acid usually has very few side
 effects
Possible side effects include:
 Serious allergic reaction, ...
Folic acid is safe to take during pregnancy
 when used as directed. It is included in
 prenatal vitamin products.
Certai...
Beta Thalassemia

 Specifically, it is characterized by a
  genetic deficiency in the synthesis
  of beta- globin chains....
Types


   Thalassemia Major
     (Cooley's anemia)
                             Thalassemia Minor
    -severe form of bet...
ETIOLOGY
Beta thalassemia is caused by a deficiency of Beta
 globin inherited in an autosomal recessive
 pattern, which m...
Etiology-cont’d
 A lack of beta-globin leads to a reduced amount of functional
  hemoglobin. Without sufficient hemoglobi...
Clinical Presentations
Thalassemia minor- characterized by mild anemia
Symptoms of beta thalassemia major appear in the fi...
Clinical Presentations
 Dark urine
 Abnormal facial bones and poor growth
 A poor appetite.
 Adolescents with the seve...
PATHOPHYSIOLOGY
 In Beta thalassemia major, patients have severe anemia, ineffective
  erythropoiesis, extramedullary hem...
 Abdominal examination may reveal changes in
  the liver, gallbladder, and spleen.
 Patients who have received blood tra...
Pathophysiology- Cont’d

 Splenomegaly typically is observed as part of the
  extramedullary hematopoiesis or as a hypert...
Surgical Treatment


Splenectomy- decrease transfusion requirements
Cholecystectomy- Patients with thalassemia
 minor ma...
TREATMENT


Treatment for beta thalassemia involves iron chelation.
1. Deferoxamine
2. Deferasirox
CURATIVE METHOD

BMT FROM COMPATIBLE     BMT FROM HAPLOIDENTICAL
       DONOR                MOTHER TO CHILD



   Free s...
EPIDEMIOLOGY
References


   American College of Obstetricians and Gynecologists (ACOG). Hemoglobinopathies in Pregnancy. ACOG Practic...
Thalassemia
Thalassemia
Thalassemia
Thalassemia
Thalassemia
Thalassemia
Upcoming SlideShare
Loading in …5
×

of

Thalassemia Slide 1 Thalassemia Slide 2 Thalassemia Slide 3 Thalassemia Slide 4 Thalassemia Slide 5 Thalassemia Slide 6 Thalassemia Slide 7 Thalassemia Slide 8 Thalassemia Slide 9 Thalassemia Slide 10 Thalassemia Slide 11 Thalassemia Slide 12 Thalassemia Slide 13 Thalassemia Slide 14 Thalassemia Slide 15 Thalassemia Slide 16 Thalassemia Slide 17 Thalassemia Slide 18 Thalassemia Slide 19 Thalassemia Slide 20 Thalassemia Slide 21 Thalassemia Slide 22 Thalassemia Slide 23 Thalassemia Slide 24 Thalassemia Slide 25 Thalassemia Slide 26 Thalassemia Slide 27 Thalassemia Slide 28 Thalassemia Slide 29 Thalassemia Slide 30 Thalassemia Slide 31 Thalassemia Slide 32 Thalassemia Slide 33 Thalassemia Slide 34 Thalassemia Slide 35
Upcoming SlideShare
Thalassemia.
Next
Download to read offline and view in fullscreen.

191 Likes

Share

Download to read offline

Thalassemia

Download to read offline

Thanks to all visiters

Related Books

Free with a 30 day trial from Scribd

See all

Related Audiobooks

Free with a 30 day trial from Scribd

See all

Thalassemia

  1. 1. INTRODUCTION  Thalassemia is an inherited autosomal recessive blood disorder.  which results in excessive destruction of red blood cells and further leads to anemia.  It is caused by variant or missing genes that affect how the body make haemoglobin.  People with thalassemia make less haemoglobin and fewer circulating red blood cells than normal ,result in mild or severe anemia.
  2. 2. ALPHA THALASSEMIA THALASSEMA BETA THALASSEMIA
  3. 3. Alpha Thalassemia  Alpha thalassemia is the result of changes in the genes for the alpha globin component in hemoglobin.  The worldwide distribution of inherited Alpha- Thalassemia is corresponding to areas of Malaria exposure.
  4. 4. ETIOLOGY  Mutation in the DNA of cells that produce hemoglobin  It is a form of thalassemia involving the genes HB1 and HB2  It is most commonly inherited in a Mendelian recessive fashion
  5. 5. PATHPHYSIOLOGY  Alpha thalassemia results when there is disturbance in production of α-globin from any or all four of the α-globin genes.  Genes are responsible for regulating the synthesis and structure of different globins which are divided into 2 clusters.  The α-globin genes are encoded on chromosome 16 and the γ, δ, and β-globin genes are encoded on chromosome 11  A normal person carries a linked pair of alpha globin genes, 2 each from maternal and paternal chromosome.
  6. 6.  Therefore, alpha thalassemia occurs when there is a disturbance in production of α-globin from any or all four of the α-globin genes.  When functional point mutations, frame shift mutations, nonsense mutations, and chain termination mutations occur within or around the coding sequences of the alpha-globin gene cluster hemoglobin is impaired.  When that occurs, protein synthesis may be inhibited.
  7. 7.  Normal production of alpha chains is absent which results in excess production of gamma- globin chains in the fetus and newborn or beta- globin chains in children and adults.  The β-globin chains are capable of forming soluble tetramers (beta-4, or HbH)  This form of hemoglobin is still unstable and precipitates within the cell, forming insoluble inclusions called Heinz bodies  These Heinz bodies damage the red blood cells.  This further results in damage to erythrocyte precursors and ineffective erythropoiesis in the bone marrow, hypochromia and microcytosis of circulating red blood cells
  8. 8. CLINICAL PRESENTATION  Shortage of red blood cells- Anemia  Pale skin  Weakness  Fatigue  Enlarged liver and spleen- hepatosplenomegaly
  9. 9.  Heart defects  Abnormalities of the urinary system or genitalia  Hb Bart syndrome can cause complications in pregnancy such as  High blood pressure  Premature delivery  Abnormal bleeding  Jaundice
  10. 10. Treatment of Alpha Thalassemia  Treatment for thalassemia often involves regular blood transfusions and folate supplements.  If you receive blood transfusions, you should not take iron supplements. Doing so can cause a high amount of iron to build up in the body, which can be harmful.  Persons who receive significant numbers of blood transfusions need a treatment called chelation therapy to remove excess iron from the body.  Bone marrow transplant may help treat the disease in some patients, especially children.
  11. 11. Surgical Treatment Perform splenectomy if transfusion requirements are increasing. Surgical or orthodontic correction may be necessary to correct skeletal deformities of the skull and maxilla caused by erythroid hyperplasia. DEFEROXAMINE - INJECTION
  12. 12. Medications FOLIC ACID- ORAL FOLIC ACID - INJECTION
  13. 13. FOLIC ACID - ORAL  BRAND NAME(S): FA-8  USES  Folic acid is the man-made form of folate which is a B6-vitamin naturally found in some foods.  It is needed to form healthy cells, especially red blood cells.  Active forms of folic acid are: L-methylfolate and levomefolate  Folic acid supplements are used to treat or prevent low folate levels.
  14. 14. SIDE EFFECTS Folic acid usually has very few side effects Possible side effects include: Serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), dizziness, trouble breathing
  15. 15. Folic acid is safe to take during pregnancy when used as directed. It is included in prenatal vitamin products. Certain spinal cord birth defects may be prevented by taking adequate amounts of folic acid during pregnancy.
  16. 16. Beta Thalassemia  Specifically, it is characterized by a genetic deficiency in the synthesis of beta- globin chains.  Beta-globin is a component (subunit) of hemoglobin.
  17. 17. Types Thalassemia Major (Cooley's anemia) Thalassemia Minor -severe form of beta thalassemia - presence of one normal gene and one with a - presence of two mutation abnormal genes that cause either a severe - causes mild to decrease or complete moderate mild lack of beta globin anemia. production.
  18. 18. ETIOLOGY Beta thalassemia is caused by a deficiency of Beta globin inherited in an autosomal recessive pattern, which means both copies of the HBB(Hemoglobin beta) gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.
  19. 19. Etiology-cont’d  A lack of beta-globin leads to a reduced amount of functional hemoglobin. Without sufficient hemoglobin, red blood cells do not develop normally, causing a shortage of mature red blood cells.  The low number of mature red blood cells leads to anemia and other associated health problems in people with beta thalassemia.
  20. 20. Clinical Presentations Thalassemia minor- characterized by mild anemia Symptoms of beta thalassemia major appear in the first two years of life.  Fatigue and weakness  Pale skin or jaundice (yellowing of the skin)  Protruding abdomen with enlarged spleen and liver
  21. 21. Clinical Presentations  Dark urine  Abnormal facial bones and poor growth  A poor appetite.  Adolescents with the severe form of beta thalassemia may experience delayed puberty.
  22. 22. PATHOPHYSIOLOGY  In Beta thalassemia major, patients have severe anemia, ineffective erythropoiesis, extramedullary hematopoiesis, and iron overload resulting from transfusion and increased iron absorption.  The skin may show pallor from anemia and jaundice from hyperbilirubinemia.  The skull and other bones may be deformed secondary to erythroid hyperplasia with intramedullary expansion and cortical bone thinning.  Heart examination may reveal findings of cardiac failure and arrhythmia, related to either severe anemia or iron overload.
  23. 23.  Abdominal examination may reveal changes in the liver, gallbladder, and spleen.  Patients who have received blood transfusions may have hepatomegaly or chronic hepatitis due to iron overload.  The gallbladder may contain bilirubin stones formed as a result of the patient's lifelong hemolytic state.
  24. 24. Pathophysiology- Cont’d  Splenomegaly typically is observed as part of the extramedullary hematopoiesis or as a hypertrophic response related to the extravascular hemolysis.  In addition to cardiac dysfunction, hepatomegaly, and hepatitis, iron overload can also cause endocrine dysfunction, especially affecting the pancreas, testes, and thyroid.  Transfusion-associated viral hepatits resulting in cirrhosis or portal hypertension also may be seen.
  25. 25. Surgical Treatment Splenectomy- decrease transfusion requirements Cholecystectomy- Patients with thalassemia minor may have bilirubin stones in their gallbladder and, if symptomatic, may require treatment. Perform a cholecystectomy using a laparoscope or carry out the procedure at the same time as the splenectomy.
  26. 26. TREATMENT Treatment for beta thalassemia involves iron chelation. 1. Deferoxamine 2. Deferasirox
  27. 27. CURATIVE METHOD BMT FROM COMPATIBLE BMT FROM HAPLOIDENTICAL DONOR MOTHER TO CHILD  Free survival 87%  Free survival 70%  Rejection 10%  Rejection 23%  Mortality 3%  Mortality 7 %
  28. 28. EPIDEMIOLOGY
  29. 29. References  American College of Obstetricians and Gynecologists (ACOG). Hemoglobinopathies in Pregnancy. ACOG Practice Bulletin, number 78, January 2007.  Beta Thalassemia. (Sept 2, 2011). Retrieved from http://emedicine.medscape.com/article/206490-overview  Bleibel, S. et al. Thalassemia, Alpha. Retrieved: 29 September, 2011 from http://emedicine.medscape.com/article/206397-overview#a0104  Cohen, A.R., et al. Thalassemia. Hematology 2004, American Society of Hematology, pages 14-34.  Cooley’s Anemia Foundation. About Thalassemia. Updated 2007.  Cunningham, M.J. Update on Thalassemia: Clinical Care and Complications. Pediatric Clinics of North America, volume 55, April 2008, pages 447-460.  Deferoxamine [Pharm GKB]. (n.d.). Retrieved from http://www.pharmgkb.org/do/serve?objId=PA164746490&objCls=Drug#tabview=tab1  Di Bartolomeo, P., et al. Long-term Results of Survival in Patients with Thalassemia Major Treated with Bone Marrow Transplantation. American Journal of Hematology, February 13, 2008 (Epub ahead of print).  Exjade (Deferasirox) Drug Information… (Aug 19, 2011). Retrieved from http://www.rxlist.com/exjade-drug.htm  Food and Drug Administration (FDA). FDA Approves First Oral Drug for Chronic Iron Overload. FDA News, November 9, 2005  Food and Drug Administration (FDA). FDA Approves First Oral Drug for Chronic Iron Overload. FDA News, November 9, 2005.  Linda J. Vorvick, MD, Medical Director, MEDEX Northwest Division of Physician Assistant Studies, University of Washington, School of Medicine; and Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital; and David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc., Review Date: 1/31/2010,Thalassemia, retrieved on 2011-09-30, http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001613/  Lucile Packard Children’s Hospital at Standford. 2011. Alpha Thalassemia. Retrieved: 29 September, 2011 from http://www.lpch.org/DiseaseHealthInfo/HealthLibrary/hematology/thalapth.htmlth
  • KeishaStewart2

    Dec. 4, 2021
  • ShreyaBansal54

    Nov. 27, 2021
  • NabeelaMunirNabeelaM

    Sep. 25, 2021
  • kushalshiva

    Aug. 23, 2021
  • AlagarasiGandhi

    Jul. 17, 2021
  • ChaudharyAditya1

    Jun. 1, 2021
  • IshaMehta41

    May. 4, 2021
  • VaibhaviBedekar

    Apr. 10, 2021
  • ThanmayiNallajeru

    Jan. 30, 2021
  • NazKhatun

    Dec. 19, 2020
  • SagarPatel382

    Dec. 14, 2020
  • RanuMadnakari

    Dec. 1, 2020
  • DanishMhd

    Nov. 28, 2020
  • janardhanachari

    Nov. 24, 2020
  • MadhaviBhor1

    Nov. 24, 2020
  • abdullahkhilji123

    Nov. 3, 2020
  • VimalKumar575

    Sep. 25, 2020
  • seekersnitch

    Sep. 22, 2020
  • AmanShaikh42

    Aug. 19, 2020
  • GIRISHKEVALDAS

    Aug. 13, 2020

Thanks to all visiters

Views

Total views

74,614

On Slideshare

0

From embeds

0

Number of embeds

88

Actions

Downloads

4,460

Shares

0

Comments

0

Likes

191

×